Cancer and Palliative Care Outcomes Centre, School of Nursing, Queensland University of Technology, Brisbane, AustraliaWallen, Matthew P.School of Science, Psychology and Sport, Federation University Australia, Victoria, AustraliaHan, Chad Y.Caring Futures Institute, College of Nursing and Health ...
Canberra, Australia, who was not involved in the study, says, "Butler and colleagues acknowledge that their findings might be 'less applicable' in people with COVID-19 who are extremely clinically vulnerable. We would go a step further and urge caution in seeking to apply...
Molnupiravir is an oral antiviral prodrug with broad activity against coronaviruses, including SARS-CoV-2 and its variants of concern. The randomized,placebo-controlled, double-blind phase 2/3 MOVe-OUT trial (already published inNEJM, see link below) confirmed superiority of molnupiravir over p...